Bioworld Financial Watch articles from January 2005

Bioworld Financial Watch archives from January 2005

Late-year approvals, decent funds sweeten biotech's 2004.
January 3, 2005... As holiday gatherings ended, the year's end neared and the influenza virus began making inroads--recalling what had to be biotechnology's main embarrassment of 2004, Chiron Corp.'s vaccine-shortage snafu--industry observers began taking stock...

10 biggest U.S. gainers for the week.
January 3, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Xenogen 36.43 Pharmos 33.94 Deltagen 33.33 StemCells 28.00 DOR BioPharma 27.27 CoTherix 25.21 ImmunoGen 22.87...

10 biggest U.S. losers for the week.
January 3, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Cellegy Pharma -41.72 Northwest BioThera -33.33 Imcor -25.68 Cygnus -20.00 XOMA -9.85 Memory -8.36...

Biotech mergers and acquisitions: Sept. 23-Dec. 28, 2004 (#).
January 3, 2005... Biotech Mergers And Acquisitions: Sept. 23-Dec. 28, 2004 (#) I. COMPLETED MERGERS AND ACQUISITIONS Company Acquired By Date Acquired * Or Merged With * Announced (Country; Symbol) (Country;...

BioWorld stock report for public biotechnology companies.
January 3, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 12/23 12/30 ...

Insmed seeks approval first in heated IGF-1 race with Tercica.(Legal Battle May Loom)
January 10, 2005... "Short people got no reason to live," Randy Newman sang in a satirical, widely misunderstood 1977 tune about discrimination against the height-challenged. As an endocrine disorder, failure to grow is a serious matter for children--and a...

10 biggest U.S. gainers for the week.
January 10, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Alliance 73.68 V.I. Technol 66.15 Aastrom Biosci 60.56 StemCells 34.75 Keryx 28.69 Deltagen 28.57 Tapestry Pharma 25.77...

10 biggest U.S. losers for the week.
January 10, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Osteotech -24.55 Immucell -23.18 Accelrys Inc -22.31 Renovis -20.65 Immunicon -20.20 Atherogenics -19.31 SuperGen ...

Public financing of biotechnology: December 2004.
January 10, 2005... Public Financing Of Biotechnology: December 2004 I. COMMENCED TRADING IN DECEMBER INITIAL OFFERINGS Company Date Date Shares/ Price (Symbol) (#) Filed Comm. Units (M) Chemokine ...

Other financings of public biotechnology companies: December 2004.
January 10, 2005... Other Financings Of Public Biotechnology Companies: December 2004 TOTAL: $1,063.07M Company Type Of Number Of Amount (Symbol) (#) Financing Shares, Units Raised ...

Venture capital and corporate investments in biotechnology companies: December 2004.
January 10, 2005... Venture Capital and Corporate Investments in Biotechnology Companies: December 2004 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $300.15M Company Location Date Amt. (M) Amphora Research...

Money raised by biotech in 2004: January-December.
January 10, 2005... Money Raised By Biotech In 2004: January-December Type of Jan. Feb. Mar. Apr. May financing Public offerings 352.1 997.8 586.6 518.2 357.9 Private biotechs 444.3 367.0...

BioWorld stock report for public biotechnology companies.
January 10, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 12/31 1/7 ...

Regeneron, Dendreon ride industry's ups and downs.(JPMorgan Healthcare Conference)
January 17, 2005... SAN FRANCISCO -- As a Pacific storm cleared after dumping days of rain on northern coastal California, the sun shone intermittently on the 23rd annual JPMorgan Healthcare Conference here, the way the figurative sun shines intermittently on the...

10 biggest U.S. gainers for the week.
January 17, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Lifecore Bio 41.80 Cel-Sci 28.36 Xenova Group 26.02 Aastrom Biosci 18.42 Immunicon 18.31 Dynavax 12.85 Emisphere 12.70...

10 biggest U.S. losers for the week.
January 17, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Imcor -55.36 Epix Pharma -34.54 Dendreon -32.72 Alliance -30.30 Xenogen -27.07 Ortec Int'l -21.85 Ista Pharma -17.38...

Clinical trials update: December 2004.
January 17, 2005... Clinical Trials Update: December 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Antisense ATL1102 Second-generation Therapeutics antisense...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: December 2004.
January 17, 2005... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: December 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Abbott Humira Adalimumab;...

FDA submissions, approvals and other actions: December 2004.
January 17, 2005... FDA Submissions, Approvals And Other Actions: December 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Abbott Humira Adalimumab; fully human Laboratories ...

BioWorld stock report for public biotechnology companies.
January 17, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Wk YTD Vol 1/7 1/14 ...

Biopure, others remain on long road with 'oxygen therapeutics'.(Chasing Artificial Blood)
January 24, 2005... Picture a biotechnology company with a great idea. Then picture FDA roadblocks, lawsuits flying, a CEO departing, the SEC investigating, potential Nasdaq delisting, and the shares, once soaring at just under $50, sinking to less than 50...

10 biggest U.S. gainers for the week.
January 24, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Aastrom Biosci 48.15 AVI BioPharma 34.45 Progenics Pharma 26.08 Advancis 21.26 CytRx 20.49 EntreMed 16.96 Avax Technol 16.67...

10 biggest U.S. losers for the week.
January 24, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Hana Bio -50.91 Simulations Plus -23.91 CollaGenex -22.39 Generex Biotech -18.29 Northwest BioThera -17.50 Alnylam -16.48 Cel-Sci...

U.S. public offering performance by underwriter: Jan. 1-Dec. 31, 2004 *.
January 24, 2005... U.S. Public Offering Performance By Underwriter: Jan. 1-Dec. 31, 2004 * Underwriter Biotechnology Date Offering Company Priced Price Per (Symbol)...

BioWorld stock report for public biotechnology companies.
January 24, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 1/14 1/21 ...

New Genzyme fight fails to overshadow TKT comeback.
January 31, 2005... Transkaryotic Therapies Inc. is "one of the greatest biotech turnarounds we've seen, ever," said Christopher Raymond, analyst with Robert Baird & Co. Think about that for a moment, while surveying last week's news: another lawsuit filed by...

10 biggest U.S. gainers for the week.
January 31, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Pharsight 55.88 Cholestech 31.24 ViaCell 23.71 Northwest BioThera 21.21 Hybridon 20.00 InSite Vision 19.48 Deltagen ...

10 biggest U.S. losers for the week.
January 31, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Imcor -40.91 Genaissance -20.79 Aastrom Biosci -20.25 Tercica -18.65 StemCells -17.57 Crucell -17.00 Aeolus -15.73...

Corrections.(Correction Notice)
January 31, 2005... The chart this week on underwriters' performance reflects the following changes to last week's chart: Robert W. Baird & Co. was added as a co-manager to the Tercica Inc. IPO; the Auxilium Pharmaceuticals Inc. IPO was led by Deutche Bank...

U.S. public offering performance by underwriter: Jan. 1-Dec. 31, 2004 *.
January 31, 2005... UNDERWRITERS' 2004: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS * Underwriter Gross (Number Of Offerings As Lead/Number Proceeds Of Offerings As Lead Or Co-manager) (M) Morgan...

BioWorld stock report for public biotechnology companies.
January 31, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close WK YTD Vol 1/21 1/28 ...